Georges Jovelet, «Le sujet psychotique et les traumatismes», L'information psychiatrique, vol.94, no4, , Pages 258 à 264 (lire en ligne)
Barnabé Kiepura, Félix-Antoine Bérubé, Lionel Cailhol, «Traitement de la dissociation dans un trouble de la personnalité limite avec trouble dissociatif de l’identité et trouble de stress post-traumatique complexe: un cas clinique», Santé mentale Quebec, vol.51, no1, , p.233 - 243 (lire en ligne)
(en) S. Guloksuz et J. van Os, «The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum», Psychological Medicine, vol.48, no2, , p.229–244 (ISSN1469-8978, PMID28689498, DOI10.1017/S0033291717001775, lire en ligne, consulté le )
(en) P. Fusar-Poli, G. Deste, R. Smieskova, S. Barlati et AR. Yung, «Cognitive functioning in prodromal psychosis: a meta-analysis», Arch Gen Psychiatry, vol.69, no6, , p.562–71 (DOI10.1001/archgenpsychiatry.2011.1592)
(en) EC. Brown, C. Tas et M. Brüne, «Potential therapeutic avenues to tackle social cognition problems in schizophrenia», Expert Rev Neurother, vol.12, no1, , p.71–81 (DOI10.1586/ern.11.183)
(en) Romme MA Honig A, «Auditory hallucinations: a comparison between patients and nonpatients», J. Nerv. Ment. Dis., vol.186, no10, , p.646–51 (DOI10.1097/00005053-199810000-00009, lire en ligne)
(en) D. A. Jauch, «Reactive psychosis. I. Does the pre-DSM-III concept define a third psychosis?», Journal of Nervous and Mental Disease, vol.176, no2, , p.72–81 (DOI10.1097/00005053-198802000-00002)
(en) M. M. Ohayon, «Hypnagogic and hypnopompic hallucinations: pathological phenomena?», British Journal of Psychiatry, vol.169, no4, , p.459–67 (DOI10.1192/bjp.169.4.459, lire en ligne)
(en) Moore THM, Zammit S, Lingford-Hughes A et al., «Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review», Lancet, vol.370, no9584, , p.319–328 (PMID17662880, DOI10.1016/S0140-6736(07)61162-3)
(en) Sewell RA, Ranganathan M, D'Souza DC., «Cannabinoids and psychosis», International review of psychiatry (Abingdon, England), vol.21, no2, , p.152–62 (PMID19367509, DOI10.1080/09540260902782802)
(en) Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM, «Gene-environment interplay between cannabis and psychosis», Schizophr Bull., vol.34, no6, , p.1111–21 (PMID18723841, PMCIDPMC2632498, DOI10.1093/schbul/sbn108)
(en) McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W., «Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies», Int J Drug Policy, vol.21, no1, , p.10–9 (PMID19783132, DOI10.1016/j.drugpo.2009.09.001)
(en) Özcan S, Soydan A, Tamam L, «Supersensitivity psychosis in a case with clozapine tolerance», Eur Rev Med Pharmacol Sci, vol.16 Suppl 4, , p.70-3. (PMID23090814, lire en ligne[PDF])modifier
Tania Lecomte, Claude Leclerc et Til Wykes, La TCC de groupe pour le traitement de la psychose: Guide de l'intervenant, PUQ, (ISBN978-2-7605-4960-9, lire en ligne).
(en) S. Guloksuz et J. van Os, «The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum», Psychological Medicine, vol.48, no2, , p.229–244 (ISSN1469-8978, PMID28689498, DOI10.1017/S0033291717001775, lire en ligne, consulté le )
(en) David B Menkes, «Transient psychotic relapse temporally related to ingestion of an "energy drink"», Med J Aust, vol.194, no4, , p.206. (PMID21401467, résumé)modifier
(en) M. D. Beer, «Psychosis: from mental disorder to disease concept», Hist Psychiatry, vol.6, no22(II), , p.177-200 (résumé)
(en) S. Guloksuz et J. van Os, «The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum», Psychological Medicine, vol.48, no2, , p.229–244 (ISSN1469-8978, PMID28689498, DOI10.1017/S0033291717001775, lire en ligne, consulté le )
(en) David B Menkes, «Transient psychotic relapse temporally related to ingestion of an "energy drink"», Med J Aust, vol.194, no4, , p.206. (PMID21401467, résumé)modifier
(en) Moore THM, Zammit S, Lingford-Hughes A et al., «Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review», Lancet, vol.370, no9584, , p.319–328 (PMID17662880, DOI10.1016/S0140-6736(07)61162-3)
(en) Sewell RA, Ranganathan M, D'Souza DC., «Cannabinoids and psychosis», International review of psychiatry (Abingdon, England), vol.21, no2, , p.152–62 (PMID19367509, DOI10.1080/09540260902782802)
(en) Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM, «Gene-environment interplay between cannabis and psychosis», Schizophr Bull., vol.34, no6, , p.1111–21 (PMID18723841, PMCIDPMC2632498, DOI10.1093/schbul/sbn108)
(en) McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W., «Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies», Int J Drug Policy, vol.21, no1, , p.10–9 (PMID19783132, DOI10.1016/j.drugpo.2009.09.001)
(en) Joanna Moncrieff, «Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse», Acta Psychiatr Scand, vol.114, no1, , p.3-13. (PMID16774655, DOI10.1111/j.1600-0447.2006.00787.x)modifier
(en) Özcan S, Soydan A, Tamam L, «Supersensitivity psychosis in a case with clozapine tolerance», Eur Rev Med Pharmacol Sci, vol.16 Suppl 4, , p.70-3. (PMID23090814, lire en ligne[PDF])modifier
(en) M. M. Ohayon, «Hypnagogic and hypnopompic hallucinations: pathological phenomena?», British Journal of Psychiatry, vol.169, no4, , p.459–67 (DOI10.1192/bjp.169.4.459, lire en ligne)
(en) Romme MA Honig A, «Auditory hallucinations: a comparison between patients and nonpatients», J. Nerv. Ment. Dis., vol.186, no10, , p.646–51 (DOI10.1097/00005053-199810000-00009, lire en ligne)